Bright Minds Biosciences (DRUG) Operating Expenses (2020 - 2026)
Bright Minds Biosciences' (DRUG) quarterly Operating Expenses came in at -$9.6 million in Q1 2026, down 508.37% YoY from $2.3 million in Q1 2025, and down 59.5% on a QoQ basis from -$6.0 million in Q4 2025.
Bright Minds Biosciences (DRUG) Operating Expenses (2020 - 2026) Analysis & Trends
Bright Minds Biosciences (DRUG) has 7 years of Operating Expenses data on file, last reported at -$9.6 million in Q1 2026.
- Quarterly Operating Expenses fell 508.37% year-over-year to -$9.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.1 million (down 199.7% YoY) and the FY2025 annual result came in at $10.0 million, up 381.22% from the prior year.
- Operating Expenses eased to -$9.6 million in Q1 2026, from -$6.0 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $16.8 million in Q3 2025 to a low of -$9.6 million in Q1 2026.
- A 5-year average of $755460.1 and a median of $951047.2 in 2023 frame the typical range for Operating Expenses.
- The widest YoY moves for Operating Expenses: up 2842.82% in 2025, down 18642.06% in 2025.
- Tracing DRUG's Operating Expenses over 5 years: stood at $1.1 million in 2022, then retreated by 15.2% to $951047.2 in 2023, then tumbled by 96.59% to $32422.2 in 2024, then tumbled by 18642.06% to -$6.0 million in 2025, then plunged by 59.5% to -$9.6 million in 2026.
- The last three Operating Expenses figures came in at -$9.6 million (Q1 2026), -$6.0 million (Q4 2025), and $16.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Bright Minds Biosciences | 733.05 Mn | 733.05 Mn | - | -9.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.59 Mn |
| Dec 31, 2025 | -6.01 Mn |
| Sep 30, 2025 | 16.81 Mn |
| Jun 30, 2025 | -4.31 Mn |
| Mar 31, 2025 | 2.35 Mn |
| Dec 31, 2024 | 32,422.24 |
| Sep 30, 2024 | 571,377.01 |
| Jun 30, 2024 | 157,133.80 |
| Mar 31, 2024 | 1.25 Mn |
| Dec 31, 2023 | 951,047.22 |
| Sep 30, 2023 | 779,792.73 |
| Jun 30, 2023 | 873,040.99 |
| Mar 31, 2023 | 1.14 Mn |
| Dec 31, 2022 | 1.12 Mn |
| Sep 30, 2022 | 2.03 Mn |
| Jun 30, 2022 | 1.68 Mn |
| Mar 31, 2022 | 3.01 Mn |
| Dec 31, 2021 | 3.22 Mn |
| Sep 30, 2021 | 4.80 Mn |
| Jun 30, 2021 | 2.25 Mn |